当前位置: 首页 > 期刊 > 《中国现代医生》 > 20206
编号:13503314
原发性输尿管癌术后辅助放疗效果分析(4)
http://www.100md.com 2020年2月25日 《中国现代医生》 20206
     [13] Hahn AW,Giri S,Pathak R,et al. Effect of adjuvant radiotherapy on survival in patients with locoregional urothelial malignancies of the upper urinary tract[J]. Anticancer Res, 2016,36(8):4051-4055.

    [14] Jwa E,Kim YS,Ahn H,et al. Adjuvant radiotherapy for stage III/IV urothelial carcinoma of the upper tract[J]. Anticancer Res,2014,34(1):333-338.

    [15] Chen B,Zeng ZC,Wang GM,et al. Radiotherapy may improve overall survival of patients with T3/T4 transitional cell carcinoma of the renal pelvis or ureter and delay bladder tumour relapse[J]. BMC Cancer,2011,11:297.

    [16] Huang YC,Chang YH,Chiu KH,et al. Adjuvant radiotherapy for locally advanced upper tract urothelial carcinoma[J]. Sci Rep,2016,6:38175.

    [17] Ozsahin M,Zouhair A,Villa S,et al. Prognostic factors in urothelial renal pelvis and ureter tumours:A multicentre Rare Cancer Network study[J]. Eur J Cancer,1999,35(5):738-743.

    [18] Roupret M,Babjuk M,Comperat E,et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma:2015 Update[J]. Eur Urol,2015,68(5):868-879.

    [19] 劉利维,韩瑞发. 原发性输尿管癌38例临床分析[J]. 现代泌尿外科杂志,2006,(1):29-31.

    [20] 王军宏,李海潮,李荣军,等. 原发性输尿管癌26例临床诊治分析[J]. 临床和实验医学杂志,2009,8(8):81-82.

    (收稿日期:2019-07-30), 百拇医药(孙权权 刘同欣 张娜)
上一页1 2 3 4